As cannabis rescheduling discussions evolve at the federal level, legal experts and equity advocates are examining the potential unintended consequences of regulatory changes on social justice initiatives. The ongoing debate over moving cannabis from Schedule I to III classification has highlighted complex questions about how federal reform might affect state-level equity programs designed to include communities most impacted by prohibition.
Brandon L. Wyatt, Esquire, a Howard Law-trained attorney, combat veteran, and board member of the Minority Cannabis Business Association (MCBA), offers insight into the legal challenges that could emerge from federal cannabis reform. His analysis focuses on how rescheduling and potential descheduling might affect minority cannabis entrepreneurs and existing state equity frameworks.
Legal Implications of Schedule III Classification
The proposed rescheduling to Schedule III presents a complex mix of opportunities and obstacles for cannabis businesses, particularly those operating under social equity programs. When asked about how Schedule III status might create both opportunities and limitations for social equity businesses, Wyatt highlighted significant operational concerns.
FDA Oversight and Compliance Barriers
“Schedule III doesn’t mean freedom. It means medical oversight, FDA approvals, and federal gatekeeping,” Wyatt explained.
While businesses might benefit from tax relief, the compliance requirements could create barriers. “Most social equity licensees can’t afford the buildout, compliance teams, or pharmaceutical-grade operations that would come with federal medical classification.”
This regulatory framework could disproportionately impact smaller operators who have already invested heavily in meeting state-level requirements. Wyatt noted that many of his clients who “barely made it through the permitting process” would face additional challenges if required to meet FDA standards for medical cannabis operations.
Interstate Commerce Threats to Equity Programs
The interstate commerce implications of federal cannabis reform present another significant legal challenge. Regarding the Dormant Commerce Clause (DCC) and its potential impact on state equity programs, Wyatt warned of constitutional issues that could arise from full descheduling.
Constitutional Challenges Under the Dormant Commerce Clause
“If cannabis is descheduled fully, your state’s residency rules for equity could be ruled unconstitutional. The DCC could rip right through programs built to prioritize impacted communities,” he said. This could allow out-of-state operators to challenge state residency requirements and other protections designed to benefit local equity businesses.
Preparing for Regulatory Uncertainty
Wyatt pointed to specific scenarios where interstate commerce could undermine local equity efforts: “Imagine an operator in Oklahoma grows cannabis dirt cheap, ships it across state lines into Maryland, and undercuts the Black-owned cultivator in Prince George’s County who invested everything he had into a license, staff, and local economy.”
For legal practitioners advising minority cannabis entrepreneurs during this period of regulatory uncertainty, Wyatt emphasizes practical compliance strategies. “Keep your books clean, your licenses current, and your partnerships community-first. Be nimble. Learn to pivot when policy shifts,” he recommended.
